COX-2 inhibition improves immunotherapy and is associated with decreased numbers of myeloid-derived suppressor cells in mesothelioma. Celecoxib influences MDSC functionJoris D. Veltman, Joost P. Hegmans|BMC Cancer|2010Cited by 284